Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.
Industry, Sector and Symbol
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone866-435-5643
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$68.43 million
Profitability
Miscellaneous
Employees471
Next Earnings Date12/5/2019 (Estimated)
OptionableNot Optionable
Livongo Health (NASDAQ:LVGO) Frequently Asked Questions
What is Livongo Health's stock symbol?
Livongo Health trades on the NASDAQ under the ticker symbol "LVGO."
How were Livongo Health's earnings last quarter?
Livongo Health (NASDAQ:LVGO) issued its quarterly earnings results on Thursday, September, 5th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.17) by $0.29. The company earned $40.90 million during the quarter, compared to analysts' expectations of $39.74 million. Livongo Health's revenue for the quarter was up 155.6% compared to the same quarter last year. View Livongo Health's Earnings History.
When is Livongo Health's next earnings date?
What guidance has Livongo Health issued on next quarter's earnings?
Livongo Health issued an update on its third quarter 2019 earnings guidance on Thursday, September, 5th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $42-43 million.
What price target have analysts set for LVGO?
10 Wall Street analysts have issued 1-year target prices for Livongo Health's stock. Their predictions range from $40.00 to $50.00. On average, they anticipate Livongo Health's stock price to reach $44.20 in the next twelve months. This suggests a possible upside of 79.0% from the stock's current price. View Analyst Price Targets for Livongo Health.
What is the consensus analysts' recommendation for Livongo Health?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Livongo Health in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Livongo Health.
Has Livongo Health been receiving favorable news coverage?
News articles about LVGO stock have been trending somewhat positive recently, InfoTrie reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Livongo Health earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Livongo Health.
Who are some of Livongo Health's key competitors?
What other stocks do shareholders of Livongo Health own?
Who are Livongo Health's key executives?
Livongo Health's management team includes the folowing people:
- Mr. Glen E. Tullman, Founder & Exec. Chairman (Age 59)
- Dr. Jennifer Schneider, Pres (Age 44)
- Mr. James Pursley, Chief Commercial Officer (Age 39)
- Mr. Zane M. Burke, CEO & Director (Age 53)
- Mr. Lee A. Shapiro, Chief Financial Officer (Age 63)
When did Livongo Health IPO?
(LVGO) raised $230 million in an IPO on Thursday, July 25th 2019. The company issued 10,700,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan served as the underwriters for the IPO and Piper Jaffray, SVB Leerink, Canaccord Genuity, KeyBanc Capital Markets and Needham & Company were co-managers.
When did Livongo Health's quiet period expire?
Livongo Health's quiet period expired on Tuesday, September 3rd. Livongo Health had issued 12,687,000 shares in its public offering on July 25th. The total size of the offering was $355,236,000 based on an initial share price of $28.00. During Livongo Health's quiet period, insiders and underwriters that worked on the IPO were restricted from issuing any research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.
How do I buy shares of Livongo Health?
Shares of LVGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Livongo Health's stock price today?
One share of LVGO stock can currently be purchased for approximately $24.69.
How big of a company is Livongo Health?
What is Livongo Health's official website?
How can I contact Livongo Health?
Livongo Health's mailing address is 150 WEST EVELYN AVENUE SUITE 150, MOUNTAIN VIEW CA, 94041. The company can be reached via phone at 866-435-5643 or via email at [email protected]
MarketBeat Community Rating for Livongo Health (NASDAQ LVGO)
MarketBeat's community ratings are surveys of what our community members think about Livongo Health and other stocks. Vote "Outperform" if you believe LVGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LVGO will underperform the S&P 500 over the long term. You may vote once every thirty days.
